Patents-Review.com
ClassID:

170712 ⎘

G01N2405/02 - CPC Classification

Classification description:

Assays, e.g. immunoassays or enzyme assays, involving lipids Triacylglycerols

Recent Application in this class:
#1
20250369986
2025-12-04

APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS

 #2
20250314671
2025-10-09

Diagnostic signature

 #3
20250020675
2025-01-16

Application of Lipid Biomarkers in Diagnosis and Early Warning of Fatty Liver in Periparturient Dairy Cows

 #4
20240142476
2024-05-02

FRATAXIN-SENSITIVE LIPID MARKERS FOR MONITORING FRATAXIN REPLACEMENT THERAPY

 #5
20240142475
2024-05-02

COMPOSITIONS AND METHODS FOR THE DETECTION OF TUBERCULOSIS

 #6
20230324418
2023-10-12

METHOD FOR DIAGNOSING AND TREATING COGNITIVE IMPAIRMENT AND USE THEREOF

 #7
20230115749
2023-04-13

PRESERVATIVE FOR IN VITRO DIAGNOSTIC REAGENT AND USE THEREOF

 #8
20220334136
2022-10-20

UNIVERSAL LIPID QUANTITATIVE STANDARDS FOR USE IN LIPIDOMICS

 #9
20220243250
2022-08-04

DETERMINATION OF INTERFERENTS IN A SAMPLE

 #10
20220214367
2022-07-07

CALIBRATION METHODS AND COMPOSITIONS FOR BIOMOLECULE ANALYSIS

 #11
20220155306
2022-05-19

Biomarkers of Breast and Lung Cancer

 #12
20210405075
2021-12-30

Nanoveson(TM): Treatment, Biomarkers and Diagnostic Tests for Liver Diseases and Comorbid Diseases

 #13
20210069145
2021-03-11

COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF

 #14
20200363419
2020-11-19

Method of diagnosing cancer based on lipidomic analysis of a body fluid

 #15
20200318155
2020-10-08

METHOD AND REAGENT FOR QUANTIFYING CHOLESTEROL IN TRIGLYCERIDE-RICH LIPOPROTEIN

 #16
20200116743
2020-04-16

Method of Assessing Liver Triglyceride Levels Using a Body Fluid Sample

 #17
20200096524
2020-03-26

PLASMA AND LIVER LIPID SPECIES AS BIOMARKERS OF FATTY LIVER

 #18
20190310270
2019-10-10

Strip for measuring blood lipids

 #19
20190302118
2019-10-03

LIPID BIOMARKERS FOR THE DIAGNOSIS OF CANCER

 #20
20190227085
2019-07-25

Low density lipoprotein triglycerides (LDL-TG) as a biomarker of cardiovascular disease and uses thereof

 #21
20190219602
2019-07-18

Diagnostic methods based on lipid profiles

 #22
20190183840
2019-06-20

COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF

 #23
20190125829
2019-05-02

METHOD FOR PREVENTING OBESITY-INDUCED FATTY LIVER BY INHIBITING KCTD17

 #24
20190113530
2019-04-18

Biomarker for the diagnosis of pulmonary hypertension (PH)

 #25
20180246112
2018-08-30

Biomarkers of Breast and Lung Cancer

 #26
20180238914
2018-08-23

MEANS AND METHODS FOR DIAGNOSING CARDIAC DISEASE IN A SUBJECT

 #27
20180161298
2018-06-14

TREATMENT OF AUTOPHAGY-RELATED DISORDERS

 #28
20180156829
2018-06-07

Nanoveson(TM): Treatment, Biomarkers and Diagnostic Tests for Liver Diseases and Comorbid Disease

 #29
20170328922
2017-11-16

METHODS AND PRODUCTS FOR LABELLING LIPIDS

 #30
20170285049
2017-10-05

Means and Methods for Diagnosing Heart Failure in a Subject

 #31
20170143657
2017-05-25

COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF

 #32
20170138965
2017-05-18

Nanoveson(TM): Treatment, Biomarkers and Diagnostic Tests for Liver Diseases and Comormid Disease

 #33
20160327579
2016-11-10

CHOLESTEROL EFFLUX CAPACITY ASSESSMENT

 #34
20160305931
2016-10-20

Multi-metabolites platform for diagnosis of acute coronary syndrome

 #35
20160299156
2016-10-13

DIABETES PANEL

 #36
20160245786
2016-08-25

LIPID BIOMARKERS OF HEALTHY AGEING

 #37
20160136123
2016-05-19

TREATMENT OF AUTOPHAGY-RELATED DISORDERS

 #38
20160018423
2016-01-21

NON-HIGH DENSITY LIPOPROTEIN DERIVED CVD MARKERS

 #39
20150331001
2015-11-19

METHODS AND APPARATUS FOR THE ANALYSIS OF FATTY ACIDS

 #40
20150031572
2015-01-29

MEANS AND METHODS FOR ASSESSING NEURONAL TOXICITY

 #41
20150011424
2015-01-08

METHOD FOR DETERMINING LIVER FAT AMOUNT AND METHOD FOR DIAGNOSING NAFLD

 #42
20140120559
2014-05-01

DIABETES PANEL

 #43
20100233724
2010-09-16

MARKERS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND METHODS OF USE THEREOF

 #44
20090191576
2009-07-30

Method and index for diagnosing insulin resistance

 #45
20080193958
2008-08-14

Microtitration plates comprising wells coated with a lipid substrate and a method of preparing